United Laboratories International Holdings Future Growth
Future criteria checks 0/6
United Laboratories International Holdings is forecast to grow earnings and revenue by 1.7% and 5.2% per annum respectively. EPS is expected to grow by 1.7% per annum. Return on equity is forecast to be 19.3% in 3 years.
Key information
1.7%
Earnings growth rate
1.7%
EPS growth rate
| Pharmaceuticals earnings growth | 9.5% |
| Revenue growth rate | 5.2% |
| Future return on equity | 19.3% |
| Analyst coverage | Good |
| Last updated | 10 Sep 2024 |
Recent future growth updates
Recent updates
Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching
Aug 30
Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified
Feb 29The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement
Jan 04United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case
Nov 26Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?
Aug 10United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?
Oct 19Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?
Mar 08The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It
Feb 18
The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 03Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?
Jan 19We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide
Jan 04These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?
Dec 07The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?
Nov 23Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 16,037 | 3,035 | N/A | N/A | 7 |
| 12/31/2025 | 15,182 | 2,911 | N/A | N/A | 8 |
| 12/31/2024 | 14,588 | 2,880 | N/A | N/A | 8 |
| 6/30/2024 | 14,009 | 2,908 | N/A | N/A | N/A |
| 3/31/2024 | 13,875 | 2,805 | N/A | N/A | N/A |
| 12/31/2023 | 13,740 | 2,701 | 1,114 | 2,439 | N/A |
| 9/30/2023 | 13,399 | 2,469 | 1,376 | 2,504 | N/A |
| 6/30/2023 | 13,059 | 2,236 | 1,637 | 2,568 | N/A |
| 3/31/2023 | 12,197 | 1,909 | 1,444 | 2,300 | N/A |
| 12/31/2022 | 11,334 | 1,581 | 1,251 | 2,031 | N/A |
| 9/30/2022 | 10,750 | 1,288 | 1,066 | 1,683 | N/A |
| 6/30/2022 | 10,166 | 995 | 882 | 1,336 | N/A |
| 3/31/2022 | 9,935 | 991 | 968 | 1,439 | N/A |
| 12/31/2021 | 9,703 | 988 | 1,055 | 1,543 | N/A |
| 9/30/2021 | 9,445 | 1,056 | 1,047 | 1,647 | N/A |
| 6/30/2021 | 9,187 | 1,123 | 1,039 | 1,752 | N/A |
| 3/31/2021 | 8,980 | 913 | 1,035 | 1,660 | N/A |
| 12/31/2020 | 8,772 | 703 | 1,030 | 1,568 | N/A |
| 9/30/2020 | 8,690 | 626 | 1,128 | 1,625 | N/A |
| 6/30/2020 | 8,607 | 549 | 1,226 | 1,683 | N/A |
| 3/31/2020 | 8,500 | 595 | 1,293 | 1,742 | N/A |
| 12/31/2019 | 8,393 | 642 | 1,361 | 1,801 | N/A |
| 9/30/2019 | 8,100 | 765 | 1,147 | 1,618 | N/A |
| 6/30/2019 | 7,808 | 888 | 932 | 1,436 | N/A |
| 3/31/2019 | 7,659 | 785 | 806 | 1,324 | N/A |
| 12/31/2018 | 7,511 | 683 | 681 | 1,213 | N/A |
| 9/30/2018 | 7,395 | 373 | 640 | 1,104 | N/A |
| 6/30/2018 | 7,280 | 64 | 599 | 995 | N/A |
| 3/31/2018 | 7,053 | 73 | N/A | 883 | N/A |
| 12/31/2017 | 6,827 | 82 | N/A | 770 | N/A |
| 9/30/2017 | 6,640 | -34 | N/A | 957 | N/A |
| 6/30/2017 | 6,454 | -150 | N/A | 1,144 | N/A |
| 3/31/2017 | 6,266 | -211 | N/A | 1,109 | N/A |
| 12/31/2016 | 6,078 | -272 | N/A | 1,074 | N/A |
| 9/30/2016 | 6,083 | -216 | N/A | 976 | N/A |
| 6/30/2016 | 6,076 | -159 | N/A | 875 | N/A |
| 3/31/2016 | 6,195 | -32 | N/A | 1,182 | N/A |
| 12/31/2015 | 6,446 | 92 | N/A | 1,516 | N/A |
| 9/30/2015 | 6,597 | 148 | N/A | 1,522 | N/A |
| 6/30/2015 | 6,711 | 201 | N/A | 1,521 | N/A |
| 3/31/2015 | 6,565 | 373 | N/A | 1,460 | N/A |
| 12/31/2014 | 6,422 | 545 | N/A | 1,400 | N/A |
| 9/30/2014 | 6,179 | 552 | N/A | 1,436 | N/A |
| 6/30/2014 | 6,101 | 574 | N/A | 1,511 | N/A |
| 3/31/2014 | 6,112 | 306 | N/A | 1,347 | N/A |
| 12/31/2013 | 5,972 | 38 | N/A | 1,155 | N/A |
| 9/30/2013 | 5,829 | 33 | N/A | 924 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 3933's forecast earnings growth (1.7% per year) is below the savings rate (2.3%).
Earnings vs Market: 3933's earnings (1.7% per year) are forecast to grow slower than the Hong Kong market (11.7% per year).
High Growth Earnings: 3933's earnings are forecast to grow, but not significantly.
Revenue vs Market: 3933's revenue (5.2% per year) is forecast to grow slower than the Hong Kong market (7.3% per year).
High Growth Revenue: 3933's revenue (5.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 3933's Return on Equity is forecast to be low in 3 years time (19.3%).